1 | affinity | 1,945 |
2 | demand | 1,813 |
3 | selectivity | 1,372 |
4 | appeal | 254 |
5 | affinities | 253 |
6 | throughput | 215 |
7 | magnification | 185 |
8 | audience | 162 |
9 | scatter | 146 |
10 | enantioselectivity | 64 |
11 | stereoselectivity | 53 |
12 | selectivities | 31 |
13 | winds | 28 |
14 | rtcb | 17 |
15 | chemoselectivity | 13 |
16 | irradiances | 12 |
17 | stereospecificity | 11 |
18 | valency | 9 |
19 | sensitivity-c | 8 |
20 | work-load | 8 |
21 | stereoselectivities | 6 |
22 | avidities | 5 |
23 | fat-fed | 5 |
24 | adaptivity | 4 |
25 | adsorbability | 4 |
26 | birthrate | 4 |
27 | glucose-treated | 4 |
28 | through-put | 4 |
29 | zp-sperm | 4 |
30 | demand/delivery | 3 |
31 | morbity | 3 |
32 | post5 | 3 |
33 | protein/low | 3 |
34 | remembrance | 3 |
35 | tangents | 3 |
36 | temperature-treated | 3 |
37 | thermal-stability | 3 |
38 | 'cause | 2 |
39 | affinity/selectivity | 2 |
40 | birthrates | 2 |
41 | chtcs | 2 |
42 | cyp81f | 2 |
43 | fluormica | 2 |
44 | gamma-oryzanolcontaining | 2 |
45 | homosubtypic | 2 |
46 | mereological | 2 |
47 | mthrnl | 2 |
48 | photoresponsivity | 2 |
49 | preception | 2 |
50 | protein/cr | 2 |
51 | protein/high | 2 |
52 | reticula | 2 |
53 | risk-hpv | 2 |
54 | scatters | 2 |
55 | sensitive-c | 2 |
56 | ta-asdas-esr | 2 |
57 | tolerogenicity | 2 |
58 | 590-1200 | 1 |
59 | ab-dsdna | 1 |
60 | advanced-collagen | 1 |
61 | afficity | 1 |
62 | aip4 | 1 |
63 | androgen/low | 1 |
64 | angiovasculogenic | 1 |
65 | anti-fix | 1 |
66 | b-glucose | 1 |
67 | business- | 1 |
68 | cardiac-risk | 1 |
69 | cell-permeability | 1 |
70 | cho/low | 1 |
71 | concentrationsria | 1 |
72 | frequency-use | 1 |
73 | intake=0.59 | 1 |
74 | ionselectivity | 1 |
75 | mufa/low | 1 |
76 | p143 | 1 |
77 | pi-values | 1 |
78 | plaque/calculus | 1 |
79 | pressure-liquid | 1 |
80 | priority.there | 1 |
81 | probabilty | 1 |
82 | recruitment/cocontraction | 1 |
83 | risk-that | 1 |
84 | rlg1 | 1 |
85 | sequence-selectivity | 1 |
86 | ses/low | 1 |
87 | site-selectivity | 1 |
88 | sitosterol/c | 1 |
89 | specific-to-nonspecific | 1 |
90 | succd | 1 |
91 | technicity | 1 |
92 | temperature-extended | 1 |
93 | temperature-gas | 1 |
94 | thermo-activity | 1 |
95 | throughput-based | 1 |
96 | znte | 1 |
97 | β-arabinofuranosylation | 1 |
98 | β-subdomain | 1 |
99 | δ-affinity | 1 |
1 | 'cause | 2 |
2 | 590-1200 | 1 |
3 | ab-dsdna | 1 |
4 | adaptivity | 4 |
5 | adsorbability | 4 |
6 | advanced-collagen | 1 |
7 | afficity | 1 |
8 | affinities | 253 |
9 | affinity | 1,945 |
10 | affinity/selectivity | 2 |
11 | aip4 | 1 |
12 | androgen/low | 1 |
13 | angiovasculogenic | 1 |
14 | anti-fix | 1 |
15 | appeal | 254 |
16 | audience | 162 |
17 | avidities | 5 |
18 | b-glucose | 1 |
19 | birthrate | 4 |
20 | birthrates | 2 |
21 | business- | 1 |
22 | cardiac-risk | 1 |
23 | cell-permeability | 1 |
24 | chemoselectivity | 13 |
25 | cho/low | 1 |
26 | chtcs | 2 |
27 | concentrationsria | 1 |
28 | cyp81f | 2 |
29 | demand | 1,813 |
30 | demand/delivery | 3 |
31 | enantioselectivity | 64 |
32 | fat-fed | 5 |
33 | fluormica | 2 |
34 | frequency-use | 1 |
35 | gamma-oryzanolcontaining | 2 |
36 | glucose-treated | 4 |
37 | homosubtypic | 2 |
38 | intake=0.59 | 1 |
39 | ionselectivity | 1 |
40 | irradiances | 12 |
41 | magnification | 185 |
42 | mereological | 2 |
43 | morbity | 3 |
44 | mthrnl | 2 |
45 | mufa/low | 1 |
46 | p143 | 1 |
47 | photoresponsivity | 2 |
48 | pi-values | 1 |
49 | plaque/calculus | 1 |
50 | post5 | 3 |
51 | preception | 2 |
52 | pressure-liquid | 1 |
53 | priority.there | 1 |
54 | probabilty | 1 |
55 | protein/cr | 2 |
56 | protein/high | 2 |
57 | protein/low | 3 |
58 | recruitment/cocontraction | 1 |
59 | remembrance | 3 |
60 | reticula | 2 |
61 | risk-hpv | 2 |
62 | risk-that | 1 |
63 | rlg1 | 1 |
64 | rtcb | 17 |
65 | scatter | 146 |
66 | scatters | 2 |
67 | selectivities | 31 |
68 | selectivity | 1,372 |
69 | sensitive-c | 2 |
70 | sensitivity-c | 8 |
71 | sequence-selectivity | 1 |
72 | ses/low | 1 |
73 | site-selectivity | 1 |
74 | sitosterol/c | 1 |
75 | specific-to-nonspecific | 1 |
76 | stereoselectivities | 6 |
77 | stereoselectivity | 53 |
78 | stereospecificity | 11 |
79 | succd | 1 |
80 | ta-asdas-esr | 2 |
81 | tangents | 3 |
82 | technicity | 1 |
83 | temperature-extended | 1 |
84 | temperature-gas | 1 |
85 | temperature-treated | 3 |
86 | thermal-stability | 3 |
87 | thermo-activity | 1 |
88 | through-put | 4 |
89 | throughput | 215 |
90 | throughput-based | 1 |
91 | tolerogenicity | 2 |
92 | valency | 9 |
93 | winds | 28 |
94 | work-load | 8 |
95 | znte | 1 |
96 | zp-sperm | 4 |
97 | β-arabinofuranosylation | 1 |
98 | β-subdomain | 1 |
99 | δ-affinity | 1 |
1 | business- | 1 |
2 | 590-1200 | 1 |
3 | rlg1 | 1 |
4 | p143 | 1 |
5 | aip4 | 1 |
6 | post5 | 3 |
7 | intake=0.59 | 1 |
8 | fluormica | 2 |
9 | concentrationsria | 1 |
10 | reticula | 2 |
11 | ab-dsdna | 1 |
12 | rtcb | 17 |
13 | sensitive-c | 2 |
14 | sensitivity-c | 8 |
15 | sitosterol/c | 1 |
16 | specific-to-nonspecific | 1 |
17 | angiovasculogenic | 1 |
18 | homosubtypic | 2 |
19 | work-load | 8 |
20 | succd | 1 |
21 | temperature-extended | 1 |
22 | fat-fed | 5 |
23 | throughput-based | 1 |
24 | temperature-treated | 3 |
25 | glucose-treated | 4 |
26 | pressure-liquid | 1 |
27 | demand | 1,813 |
28 | remembrance | 3 |
29 | audience | 162 |
30 | priority.there | 1 |
31 | b-glucose | 1 |
32 | frequency-use | 1 |
33 | 'cause | 2 |
34 | birthrate | 4 |
35 | znte | 1 |
36 | cyp81f | 2 |
37 | gamma-oryzanolcontaining | 2 |
38 | protein/high | 2 |
39 | cardiac-risk | 1 |
40 | mereological | 2 |
41 | appeal | 254 |
42 | mthrnl | 2 |
43 | zp-sperm | 4 |
44 | advanced-collagen | 1 |
45 | β-subdomain | 1 |
46 | magnification | 185 |
47 | β-arabinofuranosylation | 1 |
48 | recruitment/cocontraction | 1 |
49 | preception | 2 |
50 | protein/cr | 2 |
51 | scatter | 146 |
52 | ta-asdas-esr | 2 |
53 | temperature-gas | 1 |
54 | chtcs | 2 |
55 | winds | 28 |
56 | irradiances | 12 |
57 | avidities | 5 |
58 | affinities | 253 |
59 | selectivities | 31 |
60 | stereoselectivities | 6 |
61 | birthrates | 2 |
62 | pi-values | 1 |
63 | scatters | 2 |
64 | tangents | 3 |
65 | plaque/calculus | 1 |
66 | risk-that | 1 |
67 | through-put | 4 |
68 | throughput | 215 |
69 | risk-hpv | 2 |
70 | mufa/low | 1 |
71 | androgen/low | 1 |
72 | protein/low | 3 |
73 | cho/low | 1 |
74 | ses/low | 1 |
75 | anti-fix | 1 |
76 | valency | 9 |
77 | demand/delivery | 3 |
78 | morbity | 3 |
79 | afficity | 1 |
80 | stereospecificity | 11 |
81 | tolerogenicity | 2 |
82 | technicity | 1 |
83 | adsorbability | 4 |
84 | cell-permeability | 1 |
85 | thermal-stability | 3 |
86 | affinity | 1,945 |
87 | δ-affinity | 1 |
88 | photoresponsivity | 2 |
89 | thermo-activity | 1 |
90 | selectivity | 1,372 |
91 | sequence-selectivity | 1 |
92 | site-selectivity | 1 |
93 | affinity/selectivity | 2 |
94 | ionselectivity | 1 |
95 | stereoselectivity | 53 |
96 | enantioselectivity | 64 |
97 | chemoselectivity | 13 |
98 | adaptivity | 4 |
99 | probabilty | 1 |